Monika Linke

1.6k citations
7 papers · 1.0k indexed · 1 hit paper · h-index 6
Topics
PI3K/AKT/mTOR signaling in cancer (4 papers)Immune cells in cancer (3 papers)Mast cells and histamine (2 papers)

In The Last Decade

Monika Linke

7 papers receiving 1.0k citations

Hit Papers

Regulation of innate immune cell function by mTOR20152026201820222015200400600

Peers

Monika Linke
Comparison fields: 5 of 95
  • Immunology 472
  • Molecular Biology 442
  • Epidemiology 144
  • Cancer Research 115
  • Oncology 113
Replace Il‐Young Hwang with:
Il‐Young Hwang United States
Konstantina Lyroni Greece
Laura Tiberio Italy
Scott J. Howell United States
Junko Nishio Japan
Thomas H. Oguin United States
Hongxin Zhang China
Brett A. Duguay Canada
Rohit Reja United States
Monika Linke relative to Il‐Young Hwang United States Il‐Young Hwang's profile →
Citations per field
00.5×
Il‐Young Hwang · 1×
Citations per year

Countries citing papers authored by Monika Linke

Since Specialization
Citations

This map shows the geographic impact of Monika Linke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monika Linke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monika Linke more than expected).

Fields of papers citing papers by Monika Linke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monika Linke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monika Linke. The network helps show where Monika Linke may publish in the future.

Co-authorship network of co-authors of Monika Linke

This figure shows the co-authorship network connecting the top 25 collaborators of Monika Linke. A scholar is included among the top collaborators of Monika Linke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monika Linke. Monika Linke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 4
2 64
3 18
4 47
5 195
6
Regulation of innate immune cell function by mTORbreakdown →
622
7 66

About Monika Linke

Monika Linke is a scholar working on Immunology, Physiology and Molecular Biology, having authored 7 papers that have together received 1.0k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (4 papers), Immune cells in cancer (3 papers) and Mast cells and histamine (2 papers). The work is most often cited by research in Immunology (472 citations), Biological Psychiatry (21 citations) and Cancer Research (115 citations). Monika Linke has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Thomas Weichhart, Markus Hengstschläger, Stephanie Deborah Fritsch, Nyamdelger Sukhbaatar, Karl Katholnig, Hà Phạm, Andreas Bergthaler, Anne Miller, Zhengnan Cai and Arvand Haschemi. Their work appears in journals such as Nature reviews. Immunology, The Journal of Immunology and FEBS Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026